| 标题 |
731MO Telisotuzumab adizutecan (ABBV-400; Temab-A) in combination with bevacizumab (Bev) vs standard of care (SOC) in patients (pts) with 3L+ colorectal cancer (CRC): Dose expansion results of a phase I study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:M. Cecchini; M. Cruz-Correa; S-W. Han; K. Raghav; A. Landa Magdalena; et al 出版日期:2025-11-06 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)